Want to join the conversation?
$CL 2Q15 Call: Our robust organic sales growth is particularly notable in the face of challenging macroeconomic conditions in many markets. However, foreign exchange continues to be an even more significant headwind, and that is continuing into the third quarter. Our savings programs are delivering excellent results & our cash generation is solid.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.